Analysis of Bone Grafts and Bone Graft Substitutes Market Growth Opportunities in Niche Emerging Areas United States NB90-54
Jun 02, 2015
Analysis of Bone Grafts and Bone Graft Substitutes Market
Growth Opportunities in Niche Emerging Areas
United States
NB90-54
2NB90-54
Research Team
Venkat RajanIndustry Manager
Medical Devices
Aarti ShettySenior Research Analyst
Medical Devices
Lead Analyst
Research Director
Daniel Ruppar Director of Research
Healthcare
Strategic Review Committee Leader
3NB90-54
Contents
Section Slide Numbers
Executive Summary 4
Market Overview 7
Total Market -
• External Challenges: Drivers and Restraints 10
• Forecasts and Trends 25
• Market Share and Competitive Analysis 33
Machined Bone Allograft Market 41
Standard Bone Allograft Market 52
Demineralized Bone Matrix (DBM) Segment 63
Bone Graft Substitutes Segment 75
Bone Morphogenetic Protein (BMP) Segment 91
Cell Based Matrices Segment 54
Platelet Concentration System Segment 116
The Last Word (Conclusions and Implications) 126
Appendix 130
4NB90-54
Executive Summary—CEO’s Perspective
2Rise in popularity of cell based
matrices dictates new market trend
3Differentiation in bone graft substitutes
market is becoming the most crucial
competitive factor
4Off-label use of bone graft material is
on the rise, resulting in stricter
guidelines for use
5Increases in reconstruction and spine
surgery demand use of advanced bone
grafts
1Declining growth in the bone
morphogenetic market is decreasing
overall market revenue
Source: Frost & Sullivan analysis.
5NB90-54
Market Segmentation
Bone Grafts and Bone Graft Substitutes Market: Market Segmentation, U.S., 2011
Source: Frost & Sullivan analysis.
Platelet Concentration System segment is treated as a separate segment in the study. The overall bone
grafts and bone graft substitute market revenue is not inclusive of the platelet concentration system market.
Demineralized
Bone Matrix
(DBM)
Bone Grafts and Bone Graft Substitutes Market
Bone Graft
Substitutes
Machined
Bone
Allograft
Bone
Morphogeneti
c Protein
(BMP)
Cell Based
Matrices
Platelet
Concentration
System
Standard
Bone
Allograft
6NB90-54
Market Overview—Key Questions This Study Will Answer
Is the bone grafts market growing, how long will it continue to grow and at what rate?
What are the primary drivers of market expansion and growth opportunities in large and small
segments of the market?
Which segments are expanding the most, and which are declining?
What type of regulations are affecting the market?
Are the products/services offered today meeting customer needs or is there additional development
needed?
How is the competition in the market? Are some companies poised for more growth than others?
Source: Frost & Sullivan analysis.
7NB90-54
Drivers and Restraints
Negative media literature about tissue recovery
deters widespread adoption of biologic products.
Federal cost-cutting measures and poor
reimbursement will negatively affect business and
financial decisions
Poor or lack of reimbursement for expensive
innovative technologies obviates technology
adoption
1–2 years 3–4 years 5 years
Increase in the number of orthopedic surgeries
leads to increased usage of bone grafts.
Advances in bone graft materials creates better
results and bolsters confidence
Room for innovative products creates low barriers
for enter in some niche markets
Increasing market competition promotes
differentiation of products
Mark
et
Dri
vers
Mark
et
Restr
ain
ts
Impact: High Medium Low
Bone Graft and Bone Graft Substitutes Market: Key Market Drivers and Restraints, U.S., 2012–2016
Source: Frost & Sullivan analysis.
8NB90-54
Market Engineering Methodology
One of Frost & Sullivan’s core deliverables
is its Market Engineering studies. They
are based on our proprietary Market
Engineering Methodology. This approach,
developed across the 50 years of
experience assessing global markets,
applies engineering rigor to the often
nebulous art of market forecasting and
interpretation.
A detailed description of the methodology
can be found here.
Source: Frost & Sullivan research.